Amarantus Bioscience Holdints, Inc. (OTCMKTS:AMBS) Crashes After Q1 Report

[[tagnumber 0]][[tagnumber 1]]After a depressing performance in March we saw Amarantus Bioscience, Inc. (OTCMKTS:AMBS) try to hold it together throughout April and the ticker even managed to make an impressive climb in the middle of this month.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The upward run was fueled by some optimistic news, but unfortunately it was not meant to last for long. [[tagnumber 6]]AMBS [[tagnumber 7]]was late with its filing for the first quarter of the year which came on Tuesday and contained the following numbers in its balance sheet.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $109 thousand[[tagnumber 13]] [[tagnumber 12]]current assets: $611 thousand[[tagnumber 13]] [[tagnumber 12]]current liabilities: $7.62 million[[tagnumber 13]] [[tagnumber 12]]quarterly revenues: ZERO[[tagnumber 13]] [[tagnumber 12]]quarterly net loss: $6.58 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]These numbers were enough to disappoint investors and we saw [[tagnumber 6]]AMBS[[tagnumber 7]] lose some 21.01% in yesterday’s session. A total of 15.61 million shares, the highest in a little over a month, changed their owners and generated $934 thousand in daily dollar volume as the company stock was sliding.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Today we saw some more optimistic news come from company HQ and so far [[tagnumber 6]]AMBS [[tagnumber 7]]is stable, being traded 3.83% higher from yesterday’s close as of the writing of this article. Still, that doesn’t mean that things can’t take a turn for the worse.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]After all, the market cap of [[tagnumber 6]]AMBS[[tagnumber 7]] is not very small and the financials during the first month don’t look like the company can support itself for much longer without having to acquire financing. This may cause dilution, pushing the stock further down.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]In any case, doing your due diligence and weighing out the risks is a must.[[tagnumber 2]]